Developer docs
API playgroundTry for free, no card

Search company profiles

Onego Bio

Full company profile

uuid00009cj

Namestring
Onego Bio
Legal namestring
Onego Bio Ltd
Websiteurl
onego.bio
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Onego Bio is a Finnish food-biotech company founded in 2022 as a spin-out from VTT Technical Research Centre of Finland. It produces Bioalbumen®, a precision-fermented animal-free ovalbumin (egg white protein) ingredient marketed to industrial food manufacturers. The company operates a B2B ingredient supplier model, selling exclusively to commercial customers such as bakeries, confectionery producers, snack manufacturers, sauce makers, pasta producers, and meat alternative companies, rather than to end consumers. Revenue mechanics are quote-based B2B contracts with multi-year cadence, supported by R&D services including recipe optimization, shelf-life testing, and functional validation through its San Diego test kitchen.

The company's core technology is a proprietary Trichoderma reesei microbial platform exclusively licensed from VTT, designed to produce ovalbumin via precision fermentation at industrial scale. The platform has demonstrated 120 g/L productivity in 250,000 L fermentation vessels, and the planned Wisconsin flagship facility targets 2 million liters of fermentation capacity, equivalent to the protein output of 6 million laying hens per unit. Bioalbumen® is functionally bioidentical to conventional egg white protein, delivering all essential amino acids with a PDCAAS score of 1.0, complete functional performance (foaming, gelling, binding, emulsification), and a 2-year ambient shelf life, with company-estimated environmental footprint reductions of 95% in land use, 72-89% in greenhouse gas emissions, and 87-89% in water consumption versus conventional eggs.

As of the input data, Onego Bio is in pre-commercialization to early commercialization phase. It received FDA GRAS 'no questions' status for Bioalbumen® in September 2025 (GRN 1249), enabling U.S. market entry, and is collaborating with over 25 named CPG companies on product formulation. The company maintains R&D operations in Helsinki, U.S. commercial headquarters in San Diego opened September 2024, and is building a flagship manufacturing facility in Jefferson County, Wisconsin targeted for 2028 operations, while scaling current supply via co-manufacturers.

Short descriptiontext

Onego Bio is a Finnish food-biotech company producing Bioalbumen®, a precision-fermented animal-free ovalbumin ingredient. It sells B2B to commercial food manufacturers in bakery, confectionery, snacks, sauces, pasta, and meat alternatives, targeting the $330B global egg market.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersHelsinki, Finland
HQ citystring
Helsinki
HQ countrystring
Finland
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
precision fermentation, egg protein ingredients, alternative protein production, animal-free ovalbumin, food ingredient manufacturing
Industry1 code
PRIMARYAFAKAGAH
Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation)
Agriculture & Food Production/Food Processing & Manufacturing/Plant-Based & Alternative Protein Foods Manufacturing
SIC code2 codes
  • Food And Kindred Products2000
  • Miscellaneous Food Preparations & Kindred Products2090
Product category
Precision Fermented Egg Protein Ingredients
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Bioalbumen Ingredient Sales
TypeTransaction Fee
Description

Sale of precision-fermented egg protein (Bioalbumen) as a food ingredient to commercial food manufacturers including bakeries, confectionery producers, snack manufacturers, sauce makers, pasta producers, and meat alternative companies. Sold as a B2B ingredient rather than consumer product. The company provides R&D support including recipe optimization, shelf-life testing, and functional performance validation.

onego.bio
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Operations, Personnel, Infrastructure, Marketing or Sales
Pricing details1 tier
1B2B ingredient pricing for food manufacturers
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing negotiated directly with commercial food manufacturers. Quote-based / not publicly disclosed.

onego.bio
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Bioalbumen®
Description

Precision-fermented animal-free egg white protein powder that provides identical functionality, nutrition, and taste to conventional egg white protein with approximately 90% smaller environmental footprint.

onego.bio
Core offering1 text field

Onego Bio manufactures and sells Bioalbumen®, an animal-free egg white protein (ovalbumin) powder produced through precision fermentation using the proprietary Trichoderma reesei microbial platform. The product is sold as a B2B food ingredient to commercial food manufacturers in bakery, confectionery, snacks, sauces, pasta, and meat alternative categories, providing identical taste, nutrition, and functional properties to conventional egg protein with significantly reduced environmental footprint and supply chain stability.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 95% less land use, 89% fewer GHG emissions, 89% less water consumption vs conventional eggs
+3 more records
Product overview1 text field

Onego Bio is a US-Finnish food-biotech company with a single flagship product: Bioalbumen®, an animal-free egg white protein ingredient produced via precision fermentation using Trichoderma reesei. The company operates as a B2B ingredient supplier, targeting food manufacturers in bakery, confectionery, snacks, sauces, pasta, and meat alternatives sectors. Bioalbumen® provides the same functional, nutritional, and sensory performance as traditional eggs while offering supply stability, price predictability, and significantly reduced environmental impact. The product is currently in commercialization phase with FDA GRAS status achieved and manufacturing facility planned in Jefferson County, Wisconsin.

Product and service1 record
1Bioalbumen®
CategoryPrecision Fermented Egg Protein Ingredient
Description

Bioalbumen® is an animal-free egg white protein (ovalbumin) powder produced through precision fermentation using the proprietary Trichoderma reesei microbial platform. It delivers identical taste, nutrition (PDCAAS 1.0, 90+ g protein per 100 g), and functional properties (foaming, gelling, binding, emulsification) to conventional egg white protein. Sold as a B2B food ingredient to commercial food manufacturers in baked goods, confectionery, snacks, beverages, sauces, pasta, meat alternatives, and ready-made meals. Features 24-month ambient shelf life, eliminating cold chain requirements, with 95% less land use, 72-89% fewer GHG emissions, and 89% less water consumption compared to traditional eggs.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-05
Description

Collaboration agreement to evaluate Bioalbumen functionality and commercial potential in commercially relevant food products. Partnership focuses on addressing egg supply chain challenges including volatility, rising prices, and avian flu disruptions. Includes feasibility assessments, prototype development, and application trials.

2Jefferson County Food and Beverage Innovation Campus
Strategic tierCoreTypeOthersAnnounced on2025-03-12
Description

Site partner for flagship manufacturing facility. Company is second tenant at campus located in Jefferson County, Wisconsin. $777,000 land purchase of 25.9 acres approved by Jefferson County Board.

onego.bio
Strategic tierMinorTypeOthersAnnounced on2023-03-15
Description

Founding member together with Better Dairy, Formo, Imagindairy, and Those Vegan Cowboys. European alliance working toward forward-looking regulatory environment for sustainable animal-free foods.

Strategic tierMinorTypeOthersAnnounced on2023-02-16
Description

Founding member together with Change Foods, The EVERY Co., Helaina, Imagindairy, Motif FoodWorks, New Culture, Perfect Day, and Remilk. Industry coalition to champion precision fermentation as trusted solution for sustainable food system.

5nth Bio (Perfect Day)
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-09-20
Description

Enterprise biology partnership providing strain engineering, bioprocess development, regulatory support, and scale-up process services. nth Bio (formerly Perfect Day's enterprise biology division) offers end-to-end expertise from molecular development to commercial-scale manufacturing.

onego.bio
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-02-22
Description

Spin-out origin and technology licensor. Company acquired license to Trichoderma reesei technology developed at VTT for precision fermentation of egg proteins. VTT LaunchPad science-based spin-off incubator supported company formation.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight8 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The EVERY Company (formerly Clara Foods) is the most direct competitor, producing animal-free egg proteins via precision fermentation for food and beverage manufacturers. Overlap with Onego is near-complete in product category (precision-fermented egg white protein) and target customer base (industrial food manufacturers), making it the closest comparable for technology, customer adoption, and regulatory benchmarks.

TypeBroad incumbent
Description

Perfect Day is one of the largest precision fermentation food companies, producing animal-free whey protein for dairy applications. It is a broader incumbent (dairy rather than egg) but uses the same core precision fermentation platform and B2B ingredient business model, and has historically partnered with Onego via its enterprise biology arm.

TypeBroad incumbent
Description

Remilk produces animal-free dairy proteins via precision fermentation and operates a B2B ingredient model selling to food manufacturers. While focused on beta-lactoglobulin (dairy) rather than ovalbumin, it shares the precision fermentation production architecture, regulatory pathway, and CPG customer base.

TypeEmerging player
Description

Imagindairy produces precision-fermented non-animal dairy proteins targeting the bakery, ice cream, and cheese markets. It overlaps with Onego in production technology (precision fermentation) and the target use cases (functional protein ingredients for industrial bakeries and food manufacturers) but operates in dairy rather than egg protein.

TypeBroad incumbent
Description

Motif FoodWorks is a precision fermentation food ingredient company developing animal-free proteins and fats for plant-based meat and dairy alternatives. It shares the precision fermentation B2B ingredient model and large-scale fermentation capacity build-out, though its portfolio is broader and aimed at alternative protein applications.

TypeEmerging player
Description

New Culture produces animal-free casein proteins for cheese via precision fermentation. It shares production technology and a B2B ingredient model selling to food manufacturers, but is focused on dairy cheese proteins rather than egg white proteins.

TypeEmerging player
Description

Change Foods is developing animal-free cheese proteins via precision fermentation. As a fellow founding member of the Precision Fermentation Alliance, it shares technology, regulatory pathway considerations, and the B2B ingredient model with Onego, though its target protein is dairy casein.

TypeBroad incumbent
Description

Eat Just's JUST Egg brand is the most established commercial alternative to eggs, using mung bean protein rather than precision fermentation. It targets the same end-use cases (scrambled egg, baking, mayonnaise) and the same CPG customer base, making it a relevant commercial benchmark for the egg-alternative category.

TypeEmerging player
Description

Better Dairy is a precision fermentation company producing animal-free dairy proteins (cheese and butterfat). As a fellow founding member of Food Fermentation Europe alongside Onego, it shares technology, regulatory advocacy, and the B2B ingredient model but operates in dairy.

TypeEmerging player
Description

Those Vegan Cowboys is developing animal-free dairy proteins via precision fermentation. Co-founded Food Fermentation Europe with Onego, sharing the precision fermentation production model and European regulatory advocacy, though its target protein is dairy rather than egg.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Onego Bio

Precision Fermented Egg Protein Ingredientsonego.bio

Onego Bio is a Finnish food-biotech company producing Bioalbumen®, a precision-fermented animal-free ovalbumin ingredient. It sells B2B to commercial food manufacturers in bakery, confectionery, snacks, sauces, pasta, and meat alternatives, targeting the $330B global egg market.

What Onego Bio does

Onego Bio is a Finnish food-biotech company founded in 2022 as a spin-out from VTT Technical Research Centre of Finland. It produces Bioalbumen®, a precision-fermented animal-free ovalbumin (egg white protein) ingredient marketed to industrial food manufacturers. The company operates a B2B ingredient supplier model, selling exclusively to commercial customers such as bakeries, confectionery producers, snack manufacturers, sauce makers, pasta producers, and meat alternative companies, rather than to end consumers. Revenue mechanics are quote-based B2B contracts with multi-year cadence, supported by R&D services including recipe optimization, shelf-life testing, and functional validation through its San Diego test kitchen.

The company's core technology is a proprietary Trichoderma reesei microbial platform exclusively licensed from VTT, designed to produce ovalbumin via precision fermentation at industrial scale. The platform has demonstrated 120 g/L productivity in 250,000 L fermentation vessels, and the planned Wisconsin flagship facility targets 2 million liters of fermentation capacity, equivalent to the protein output of 6 million laying hens per unit. Bioalbumen® is functionally bioidentical to conventional egg white protein, delivering all essential amino acids with a PDCAAS score of 1.0, complete functional performance (foaming, gelling, binding, emulsification), and a 2-year ambient shelf life, with company-estimated environmental footprint reductions of 95% in land use, 72-89% in greenhouse gas emissions, and 87-89% in water consumption versus conventional eggs.

As of the input data, Onego Bio is in pre-commercialization to early commercialization phase. It received FDA GRAS 'no questions' status for Bioalbumen® in September 2025 (GRN 1249), enabling U.S. market entry, and is collaborating with over 25 named CPG companies on product formulation. The company maintains R&D operations in Helsinki, U.S. commercial headquarters in San Diego opened September 2024, and is building a flagship manufacturing facility in Jefferson County, Wisconsin targeted for 2028 operations, while scaling current supply via co-manufacturers.

Onego Bio firmographics

Firmographics
Name
Onego Bio
Legal name
Onego Bio Ltd
Website
https://onego.bio
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
51–100 employees
Short description
Onego Bio is a Finnish food-biotech company producing Bioalbumen®, a precision-fermented animal-free ovalbumin ingredient. It sells B2B to commercial food manufacturers in bakery, confectionery, snacks, sauces, pasta, and meat alternatives, targeting the $330B global egg market.
Ownership category
akta.pro rank

Onego Bio industry classification

Industry
Product category
Precision Fermented Egg Protein Ingredients
SIC
Food And Kindred Products (2000), Miscellaneous Food Preparations & Kindred Products (2090)
akta.pro industry
PRIMARYAFAKAGAH
Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation)
Agriculture & Food Production/Food Processing & Manufacturing/Plant-Based & Alternative Protein Foods Manufacturing

Keywords

  • Precision fermentation
  • Egg protein ingredients
  • Alternative protein production
  • Animal-free ovalbumin
  • Food ingredient manufacturing

Where Onego Bio is headquartered

Location

Headquarters

HQ city
Helsinki
HQ country
Finland
HQ region
Europe

Offices3 records

Markets served

Onego Bio business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Personnel, Infrastructure, Marketing or Sales

Revenue model

  1. Bioalbumen Ingredient Sales: Sale of precision-fermented egg protein (Bioalbumen) as a food ingredient to commercial food manufacturers including bakeries, confectionery producers, snack manufacturers, sauce makers, pasta producers, and meat alternative companies. Sold as a B2B ingredient rather than consumer product. The company provides R&D support including recipe optimization, shelf-life testing, and functional performance validation.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B ingredient pricing for food manufacturers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Onego Bio product offering

Product offering

Core offering

Onego Bio manufactures and sells Bioalbumen®, an animal-free egg white protein (ovalbumin) powder produced through precision fermentation using the proprietary Trichoderma reesei microbial platform. The product is sold as a B2B food ingredient to commercial food manufacturers in bakery, confectionery, snacks, sauces, pasta, and meat alternative categories, providing identical taste, nutrition, and functional properties to conventional egg protein with significantly reduced environmental footprint and supply chain stability.

Product overview

Onego Bio is a US-Finnish food-biotech company with a single flagship product: Bioalbumen®, an animal-free egg white protein ingredient produced via precision fermentation using Trichoderma reesei. The company operates as a B2B ingredient supplier, targeting food manufacturers in bakery, confectionery, snacks, sauces, pasta, and meat alternatives sectors. Bioalbumen® provides the same functional, nutritional, and sensory performance as traditional eggs while offering supply stability, price predictability, and significantly reduced environmental impact. The product is currently in commercialization phase with FDA GRAS status achieved and manufacturing facility planned in Jefferson County, Wisconsin.

Differentiator

Problem solved

Functional benefit

Brands

  • Bioalbumen®: Precision-fermented animal-free egg white protein powder that provides identical functionality, nutrition, and taste to conventional egg white protein with approximately 90% smaller environmental footprint.

Products and services

  • Bioalbumen® Bioalbumen® is an animal-free egg white protein (ovalbumin) powder produced through precision fermentation using the proprietary Trichoderma reesei microbial platform. It delivers identical taste, nutrition (PDCAAS 1.0, 90+ g protein per 100 g), and functional properties (foaming, gelling, binding, emulsification) to conventional egg white protein. Sold as a B2B food ingredient to commercial food manufacturers in baked goods, confectionery, snacks, beverages, sauces, pasta, meat alternatives, and ready-made meals. Features 24-month ambient shelf life, eliminating cold chain requirements, with 95% less land use, 72-89% fewer GHG emissions, and 89% less water consumption compared to traditional eggs.

Quantifiable outcome

  • 95% less land use, 89% fewer GHG emissions, 89% less water consumption vs conventional eggs
  • +3 more outcomes

Companies that use Onego Bio

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Onego Bio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Onego Bio partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Sigma FoodscoreStrategic or Co-development Partner · 5 March 2026Collaboration agreement to evaluate Bioalbumen functionality and commercial potential in commercially relevant food products. Partnership focuses on addressing egg supply chain challenges including volatility, rising prices, and avian flu disruptions. Includes feasibility assessments, prototype development, and application trials.
  • Jefferson County Food and Beverage Innovation CampuscoreOthers · 12 March 2025Site partner for flagship manufacturing facility. Company is second tenant at campus located in Jefferson County, Wisconsin. $777,000 land purchase of 25.9 acres approved by Jefferson County Board.
  • Food Fermentation EuropeminorOthers · 15 March 2023Founding member together with Better Dairy, Formo, Imagindairy, and Those Vegan Cowboys. European alliance working toward forward-looking regulatory environment for sustainable animal-free foods.
  • Precision Fermentation AllianceminorOthers · 16 February 2023Founding member together with Change Foods, The EVERY Co., Helaina, Imagindairy, Motif FoodWorks, New Culture, Perfect Day, and Remilk. Industry coalition to champion precision fermentation as trusted solution for sustainable food system.
  • nth Bio (Perfect Day)coreTechnology or Integration · 20 September 2022Enterprise biology partnership providing strain engineering, bioprocess development, regulatory support, and scale-up process services. nth Bio (formerly Perfect Day's enterprise biology division) offers end-to-end expertise from molecular development to commercial-scale manufacturing.
  • VTT Technical Research Centre of FinlandcoreTechnology or Integration · 22 February 2022Spin-out origin and technology licensor. Company acquired license to Trichoderma reesei technology developed at VTT for precision fermentation of egg proteins. VTT LaunchPad science-based spin-off incubator supported company formation.

Scale indicators12 records

Recent moves9 records

Expansion highlights8 records

Onego Bio competitors and assessment

Company assessment

Direct peers

  • The EVERY Company: The EVERY Company (formerly Clara Foods) is the most direct competitor, producing animal-free egg proteins via precision fermentation for food and beverage manufacturers. Overlap with Onego is near-complete in product category (precision-fermented egg white protein) and target customer base (industrial food manufacturers), making it the closest comparable for technology, customer adoption, and regulatory benchmarks.

Broad incumbents

  • Perfect Day: Perfect Day is one of the largest precision fermentation food companies, producing animal-free whey protein for dairy applications. It is a broader incumbent (dairy rather than egg) but uses the same core precision fermentation platform and B2B ingredient business model, and has historically partnered with Onego via its enterprise biology arm.
  • Remilk: Remilk produces animal-free dairy proteins via precision fermentation and operates a B2B ingredient model selling to food manufacturers. While focused on beta-lactoglobulin (dairy) rather than ovalbumin, it shares the precision fermentation production architecture, regulatory pathway, and CPG customer base.
  • Motif FoodWorks: Motif FoodWorks is a precision fermentation food ingredient company developing animal-free proteins and fats for plant-based meat and dairy alternatives. It shares the precision fermentation B2B ingredient model and large-scale fermentation capacity build-out, though its portfolio is broader and aimed at alternative protein applications.
  • Eat Just (JUST Egg): Eat Just's JUST Egg brand is the most established commercial alternative to eggs, using mung bean protein rather than precision fermentation. It targets the same end-use cases (scrambled egg, baking, mayonnaise) and the same CPG customer base, making it a relevant commercial benchmark for the egg-alternative category.

Emerging players

  • Imagindairy: Imagindairy produces precision-fermented non-animal dairy proteins targeting the bakery, ice cream, and cheese markets. It overlaps with Onego in production technology (precision fermentation) and the target use cases (functional protein ingredients for industrial bakeries and food manufacturers) but operates in dairy rather than egg protein.
  • New Culture: New Culture produces animal-free casein proteins for cheese via precision fermentation. It shares production technology and a B2B ingredient model selling to food manufacturers, but is focused on dairy cheese proteins rather than egg white proteins.
  • Change Foods: Change Foods is developing animal-free cheese proteins via precision fermentation. As a fellow founding member of the Precision Fermentation Alliance, it shares technology, regulatory pathway considerations, and the B2B ingredient model with Onego, though its target protein is dairy casein.
  • Better Dairy: Better Dairy is a precision fermentation company producing animal-free dairy proteins (cheese and butterfat). As a fellow founding member of Food Fermentation Europe alongside Onego, it shares technology, regulatory advocacy, and the B2B ingredient model but operates in dairy.
  • Those Vegan Cowboys: Those Vegan Cowboys is developing animal-free dairy proteins via precision fermentation. Co-founded Food Fermentation Europe with Onego, sharing the precision fermentation production model and European regulatory advocacy, though its target protein is dairy rather than egg.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights7 records

Customer concentration

Onego Bio social profiles

Digital presence

Onego Bio compliance and trust

Trust signal

Compliance2 records

Onego Bio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Onego Bio leadership team

Management profile

Number of profiles

Profiles5 records

Onego Bio funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Onego Bio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Onego Bio

What does Onego Bio do?

Onego Bio manufactures and sells Bioalbumen®, an animal-free egg white protein (ovalbumin) powder produced through precision fermentation using the proprietary Trichoderma reesei microbial platform. The product is sold as a B2B food ingredient to commercial food manufacturers in bakery, confectionery, snacks, sauces, pasta, and meat alternative categories, providing identical taste, nutrition, and functional properties to conventional egg protein with significantly reduced environmental footprint and supply chain stability.

Is Onego Bio a public or private company?

Onego Bio is a private company. It is classified as venture growth investor backed and is currently operating.

When was Onego Bio founded?

Onego Bio was founded in 2022. It employs 51 to 100 people.

Where is Onego Bio based?

Onego Bio is headquartered in Helsinki, Finland, in the Europe region.

How does Onego Bio make money?

One revenue line is on record: bioalbumen Ingredient Sales.

Who are Onego Bio's main competitors?

The EVERY Company is listed as a direct peer. Broad incumbents are Perfect Day, Remilk, Motif FoodWorks and Eat Just (JUST Egg). Emerging players are Imagindairy, New Culture, Change Foods, Better Dairy and Those Vegan Cowboys.

Does Onego Bio have an API?

No public API is recorded for Onego Bio.

What industry is Onego Bio in?

Onego Bio's product category is Precision Fermented Egg Protein Ingredients. Its primary akta.pro industry code is AFAKAGAH, Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation). Its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
vegconomistOnego Bio’s Patent Challenge Against EVERY Dismissed in DelawareA Delaware federal court dismissed Onego Bio's lawsuit against The EVERY Company, closing the last active case in a year-long dispute over a patent for ovalbumin production. The court declined to issue a declaratory judgment and made no ruling on patent validity or infringement. Onego continues to sell its Bioalbumen egg protein to US customers.AgFunderNewsBREAKING: The EVERY Co prevails in legal spat with Onego BioA Delaware court dismissed Onego Bio's lawsuit against The EVERY Company, ending a legal dispute over ovalbumin production via precision fermentation. The court found Onego had tried to provoke litigation, and no ruling on patent validity was made. Onego said the decision provided clarity, while EVERY vowed to defend its position.Perishable NewsOnego Bio and Zen Waffles Announce Commercial Partnership to Bring Bioalbumen to the High-Protein Breakfast CategoryOnego Bio and Zen Waffles announced a commercial partnership to supply Bioalbumen, a non-animal egg protein, for Zen Waffles' high-protein waffles. The partnership brings Bioalbumen into the high-protein breakfast category, with U.S. retail sales of high-protein packaged foods growing 25% since 2021 to nearly $24 billion in 2025.Food Business NewsOnego Bio, Zen Waffles form partnershipOnego Bio and Zen Waffles formed a commercial partnership to use Onego Bio's Bioalbumen ingredient in Zen Waffles' high-protein waffles. The waffles contain 23-28 grams of protein per serving, and Bioalbumen is a non-animal egg protein made via precision fermentation. Onego Bio received a GRAS letter from the FDA in 2025.TalouselamaPaperiteollisuudesta nousee yhtiöitä aivan toiselle sektorille – Tänne syydetään nyt miljooniaLauri Reuter, a Nordic Foodtech VC partner, said a second 80-million-euro fund is nearly ready, targeting food-tech companies emerging from paper and pulp industries. He cited Enifer and Onego Bion as Finnish examples, and noted Denmark and Sweden are advancing biotech. The fund aims to support companies like Evodia, which makes beer flavorings from yeast.KauppalehtiPaperiteollisuudesta nousee yhtiöitä täysin uudelle sektorille – Tänne syydetään nyt miljooniaNordic Foodtech's second investment fund is nearly complete at about 80 million euros, with paper and pulp industry firms entering foodtech. Examples include Enifer and Onego Bion in Finland, and biotech firms in Denmark and Sweden. The company also discussed electricity costs with minister Sari Multala.vegconomistOnego Bio Moves Bioalbumen Into Packaged Breakfast With Zen Waffles Supply DealOnego Bio signed a commercial supply agreement with Zen Waffles to use its precision-fermented egg protein Bioalbumen in waffle products. Bioalbumen replaces conventional egg white protein and carries structural and browning functions. The deal follows FDA GRAS clearance and marks a US commercialization step.FinancialContent Business PageOnego Bio and Zen Waffles Announce Commercial Partnership to Bring Bioalbumen® to the High-Protein Breakfast CategoryOnego Bio and Zen Waffles announced a commercial partnership to supply Bioalbumen, a non-animal egg protein, for Zen Waffles products. The partnership targets the high-protein breakfast category, where U.S. retail sales of high-protein packaged foods grew 25% since 2021 to nearly $24 billion in 2025.Business Wire BlogOnego Bio and Zen Waffles Announce Commercial Partnership to Bring Bioalbumen® to the High-Protein Breakfast CategoryOnego Bio and Zen Waffles announced a commercial partnership to supply Bioalbumen, a non-animal egg protein, for Zen Waffles products. The partnership targets the high-protein breakfast category, where U.S. retail sales of high-protein packaged foods grew 25% since 2021 to nearly $24 billion in 2025.Tech TimesADM Converts Iowa Tanks for Precision Fermentation Egg Protein: Demand Up 550% Amid Bird FluIowa awarded Archer Daniels Midland $2.23 million in tax credits to convert 463,503 square feet of idle fermentation space at its Clinton corn complex into a precision fermentation facility producing recombinant ovalbumin, a $55.5 million investment adding 53 jobs. The Every Company reported 2026 orders up 550% over 2025, with US volumes expected to rise fivefold by 2027. Ongoing patent litigation with Onego Bio remains unresolved.